​
​

ALX Oncology (ALXO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

ALX Oncology Revenue Highlights

00

ALX Oncology Revenue by Period

ALX Oncology Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$1.18M-75.35%
2019-12-31$4.80M132.03%
2018-12-31$2.07M-

ALX Oncology generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

ALX Oncology Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.48M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$1.18100.00%
2020-09-30--100.00%
2020-06-30$527.00K-19.54%
2020-03-31$655.00K-46.00%
2019-12-31$1.21M-3.42%
2019-09-30$1.26M-3.01%
2019-06-30$1.29M25.48%
2019-03-31$1.03M-

ALX Oncology generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

ALX Oncology Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IMTXImmatics$54.00M$30.45M
EYPTEyePoint Pharmaceuticals$46.02M$10.52M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
STOKStoke Therapeutics$8.78M$4.89M
CRNXCrinetics Pharmaceuticals$4.01M-
IPSCCentury Therapeutics$2.23M$791.00K
BCELAtreca$770.00K$80.00K
CGEMCullinan Oncology--
ALXOALX Oncology--
BDTXBlack Diamond Therapeutics--
CCCCC4 Therapeutics--
CABACabaletta Bio--
BCABBioAtla-$11.00M
AVTEAerovate Therapeutics--
DYNDyne Therapeutics--
VIRXViracta Therapeutics--
PASGPassage Bio--
BMEABiomea Fusion--
MLYSMineralys Therapeutics--
EWTXEdgewise Therapeutics--

ALXO Revenue FAQ

What is ALX Oncology’s yearly revenue?

ALX Oncology's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ALXO's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.

What is ALX Oncology’s quarterly revenue?

ALX Oncology's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). ALXO's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is ALX Oncology’s revenue growth rate?

ALX Oncology's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.